Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

BACKGROUND: Diabetes is a chronic disease with several long-term complications. Several glucose-lowering drugs are used to treat type 2 diabetes mellitus (T2DM), e.g., glimepiride and liraglutide, in which both having different modes of action. Circulating microRNAs (miRNAs) are suggested as potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherbak, Nikolai N., Kruse, Robert, Nyström, Thomas, Jendle, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555542/
https://www.ncbi.nlm.nih.gov/pubmed/37349083
http://dx.doi.org/10.4093/dmj.2022.0342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555542/
https://www.ncbi.nlm.nih.gov/pubmed/37349083
http://dx.doi.org/10.4093/dmj.2022.0342

Ejemplares similares